GVCCX
Price
$7.08
Change
-$0.08 (-1.12%)
Updated
Jun 13 closing price
Net Assets
211.94M
JVMSX
Price
$27.43
Change
-$0.32 (-1.15%)
Updated
Jun 13 closing price
Net Assets
21.46B
Interact to see
Advertisement

GVCCX vs JVMSX

Header iconGVCCX vs JVMSX Comparison
Open Charts GVCCX vs JVMSXBanner chart's image
Gabelli Value 25 C
Price$7.08
Change-$0.08 (-1.12%)
VolumeN/A
Net Assets211.94M
JHancock Disciplined Value Mid Cap R2
Price$27.43
Change-$0.32 (-1.15%)
VolumeN/A
Net Assets21.46B
GVCCX vs JVMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GVCCX vs. JVMSX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVCCX is a Buy and JVMSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMSX has more cash in the bank: 21.5B vs. GVCCX (212M). JVMSX pays higher dividends than GVCCX: JVMSX (0.43) vs GVCCX (0.00). GVCCX was incepted earlier than JVMSX: GVCCX (25 years) vs JVMSX (13 years). GVCCX (2.20) is less costly to investors than JVMSX (1.26). JVMSX is a more actively managed with annual turnover of: 47.00 vs. GVCCX (5.00). JVMSX has a lower initial minimum investment than GVCCX: JVMSX (0) vs GVCCX (1000). GVCCX annual gain was more profitable for investors over the last year : 9.94 vs. JVMSX (-3.29). JVMSX return over 5 years is better than : 50.13 vs. GVCCX (-15.94).
GVCCXJVMSXGVCCX / JVMSX
Total Expense Ratio2.201.25176%
Annual Report Gross Expense Ratio2.201.26175%
Fund Existence25 years13 years-
Gain YTD8.2572.313357%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets212M21.5B1%
Annual Yield % from dividends0.000.43-
Returns for 1 year9.94-3.29-302%
Returns for 3 years-7.6915.80-49%
Returns for 5 years-15.9450.13-32%
Returns for 10 years-55.3233.43-165%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNP223.37-2.12
-0.94%
Union Pacific Corp
PNFP102.06-3.46
-3.28%
Pinnacle Financial Partners
KULR1.15-0.08
-6.50%
KULR Technology Group
PRLD0.96-0.08
-7.68%
Prelude Therapeutics
EVEX5.07-0.48
-8.65%
Eve Holding